This is a Validated Antibody Database (VAD) review about human KIR2DS5, based on 7 published articles (read how Labome selects the articles), using KIR2DS5 antibody in all methods. It is aimed to help Labome visitors find the most suited KIR2DS5 antibody. Please note the number of articles fluctuates since newly identified citations are added and citations for discontinued catalog numbers are removed regularly.
KIR2DS5 synonym: CD158G; NKAT9; killer cell immunoglobulin-like receptor 2DS5; CD158 antigen-like family member G; NKAT-9; killer Ig receptor; killer cell immunoglobulin-like receptor, two domains, short cytoplasmic tail, 5; natural killer cell inhibitory receptor; natural killer-associated transcript 9
Invitrogen
mouse monoclonal (HP-MA4) |
| Invitrogen KIR2DS5 antibody (eBioscience, HP-MA4) was used in flow cytometry on human samples . Biol Blood Marrow Transplant (2014) ncbi |
mouse monoclonal (HP-MA4) |
| In order to quantify coexpression of different killer Ig-like molecules in patient natural killer cells with mutant TAP genes mediating deficient HLA class I expression, Invitrogen KIR2DS5 antibody (eBioscience, HP-MA4) was used in flow cytometry on human samples . J Immunol (2014) ncbi |
Beckman Coulter
mouse monoclonal (EB6B) |
| Beckman Coulter KIR2DS5 antibody (Beckman Coulter, A66899) was used in flow cytometry on human samples (fig 5a). J Immunol (2018) ncbi |
mouse monoclonal (EB6B) |
| Beckman Coulter KIR2DS5 antibody (Beckman Coulter, EB6) was used in flow cytometry on human samples (fig s1). Eur J Immunol (2018) ncbi |
mouse monoclonal (EB6B) |
| Beckman Coulter KIR2DS5 antibody (Beckman Coulter, EB6B) was used in flow cytometry on human samples (fig 3b). Immun Ageing (2017) ncbi |
mouse monoclonal (EB6B) |
| Beckman Coulter KIR2DS5 antibody (Beckman Coulter, EB6) was used in flow cytometry on human samples . J Immunol (2014) ncbi |
mouse monoclonal (EB6B) |
| Beckman Coulter KIR2DS5 antibody (Beckman Coulter, EB6.B) was used in flow cytometry on human samples (fig 2). Eur J Immunol (2015) ncbi |
Articles Reviewed
- Miller J, Rooney C, Curtsinger J, McElmurry R, McCullar V, Verneris M, et al. Expansion and homing of adoptively transferred human natural killer cells in immunodeficient mice varies with product preparation and in vivo cytokine administration: implications for clinical therapy. Biol Blood Marrow Transplant. 2014;20:1252-7 pubmed publisher
contribute
- If you are aware of any publication with knockout studies validating a monoclonal or recombinant antibody, either purchased from a supplier or developed by the author(s), please notify us through feedback.
questions and comments